Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03163017
Other study ID # HSC-MS-16-0840
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date March 1, 2017
Est. completion date September 11, 2018

Study information

Verified date August 2019
Source The University of Texas Health Science Center, Houston
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to determine if use of new imaging technology termed "3D fluoroscopy" will lead the surgeon to change the position of the fractured bones to a more accurate position.


Recruitment information / eligibility

Status Completed
Enrollment 30
Est. completion date September 11, 2018
Est. primary completion date September 11, 2018
Accepts healthy volunteers No
Gender All
Age group 18 Years to 75 Years
Eligibility Inclusion Criteria:

- Skeletally mature

- Patients with unilateral, acute, displaced ankle fractures with preoperative evidence of syndesmotic disruption or intraoperative evidence of syndesmotic instability following malleolar fixation.

Exclusion Criteria:

- Patients skeletally immature;

- Patients less than age 18 years and more than age 75;

- Patients with previous ankle trauma to either ankle;

- Patients with bilateral ankle injuries;

- Patients with previous osseous injuries to the tibia or fibula; and

- Patients with isolated syndesmotic injury and no fracture (i.e. high ankle sprains)

Study Design


Related Conditions & MeSH terms


Intervention

Device:
2D Fluoroscopy
Patients with syndesmotic instability will undergo reduction of the syndesmosis followed by provisional fixation with a clamp or Kirshner wire. The reduction quality will be initially compared to the contralateral ankle mortise and talar-dome lateral radiographs using the technique of Summers et al i.e. 2D Fluoroscopy using device Ziehm Vision RFD 3D image-intensified fluoroscopic x-ray system.
3D Fluoroscopy
After the attending surgeon is satisfied with the reduction quality from 2D Fluoroscopy, 3D fluoroscopy using device Ziehm Vision RFD 3D image-intensified fluoroscopic x-ray system will be used to generate additional images to assess syndesmotic and fibular reductions.

Locations

Country Name City State
United States The University of Texas at Health Science Center at Houston Houston Texas

Sponsors (2)

Lead Sponsor Collaborator
The University of Texas Health Science Center, Houston AO Trauma North America

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Number of Participants for Which the Surgeon Changed Reduction of Syndesmotic Reduction Because of Information Provided by 3D Fluoroscopy Patients with syndesmotic instability will undergo reduction of the syndesmosis followed by provisional fixation with a clamp or Kirshner wire. The reduction quality will be initially compared to the contralateral ankle mortise and talar-dome lateral radiographs using the technique of Summers (2D Fluoroscopy). After the attending surgeon is satisfied with the reduction quality, 3D fluoroscopy will be used to generate additional images to assess syndesmotic reductions. Immediately at the time of 3D Fluoroscopy
Secondary Number of Participants for Which the Surgeon Changed Reduction of Fibular Fracture Reduction Because of Information Provided by 3D Fluoroscopy Patients with syndesmotic instability will undergo reduction of the syndesmosis followed by provisional fixation with a clamp or Kirshner wire. The reduction quality will be initially compared to the contralateral ankle mortise and talar-dome lateral radiographs using the technique of Summers (2D Fluoroscopy). After the attending surgeon is satisfied with the reduction quality, 3D fluoroscopy will be used to generate additional images to assess fibular fracture reductions. Immediately at the time of 3D Fluoroscopy
Secondary Pain as Assessed by the AOFAS Score The patient outcome variables studied will include American Orthopedic Foot and Ankle Society (AOFAS) scores 3 months after 3D Fluoroscopy
Secondary Function as Assessed by the AOFAS Score The patient outcome variables studied will include American Orthopedic Foot and Ankle Society (AOFAS) scores 3 months after 3D Fluoroscopy
Secondary Alignment as Assessed by the AOFAS Score The patient outcome variables studied will include American Orthopedic Foot and Ankle Society (AOFAS) scores 3 months after 3D Fluoroscopy
Secondary Pain as Assessed by the AOFAS Score The patient outcome variables studied will include American Orthopedic Foot and Ankle Society (AOFAS) scores 6 months after 3D Fluoroscopy
Secondary Function as Assessed by the AOFAS Score The patient outcome variables studied will include American Orthopedic Foot and Ankle Society (AOFAS) scores 6 months after 3D Fluoroscopy
Secondary Alignment as Assessed by the AOFAS Score The patient outcome variables studied will include American Orthopedic Foot and Ankle Society (AOFAS) scores 6 months after 3D Fluoroscopy
Secondary Pain as Assessed by the PROMIS Score Patient-Reported Outcomes Measurement Information System (PROMIS) patient physical health outcome measures 3 months after 3D Fluoroscopy
Secondary Function as Assessed by the PROMIS Score Patient-Reported Outcomes Measurement Information System (PROMIS) patient physical health outcome measures 3 months after 3D Fluoroscopy
Secondary Pain as Assessed by the PROMIS Score Patient-Reported Outcomes Measurement Information System (PROMIS) patient physical health outcome measures 6 months after 3D Fluoroscopy
Secondary Function as Assessed by the PROMIS Score Patient-Reported Outcomes Measurement Information System (PROMIS) patient physical health outcome measures 6 months after 3D Fluoroscopy
Secondary Number of Participants With Syndesmotic Malreduction as Assessed by a Single Postoperative Bilateral CT Scan Malreduction will be determined by comparing uninjured ankle to the injured ankle 1 day after 3D Fluoroscopy